<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>sgs3.txt
<TEXT>

  AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 18, 2002

                                                      REGISTRATION NO. 333-

===========================================================================

                               UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, DC 20549

                    -----------------------------------

                                  FORM S-3
                      REGISTRATION STATEMENT UNDER THE
                           SECURITIES ACT OF 1933

                    -----------------------------------

                              SPX CORPORATION
           (Exact Name of Registrant as Specified in Its Charter)

          DELAWARE                                        38-1016240
(State or Other Jurisdiction of                         (I.R.S. Employer
Incorporation or Organization)                      Identification Number)

                    -----------------------------------

                          2300 ONE WACHOVIA CENTER
                          301 SOUTH COLLEGE STREET
                          CHARLOTTE, NC 28202-6039
                               (704) 347-6800
                (Address, Including Zip Code, and Telephone
                Number, Including Area Code, of Registrant's
                        Principal Executive Offices)
                    -----------------------------------

                        CHRISTOPHER J. KEARNEY, ESQ.
                     VICE PRESIDENT AND GENERAL COUNSEL
                              SPX CORPORATION
                          2300 ONE WACHOVIA CENTER
                          301 SOUTH COLLEGE STREET
                          CHARLOTTE, NC 28202-6039
                               (704) 347-6800
         (Name, Address, Including Zip Code, and Telephone Number,
                 Including Area Code, of Agent For Service)

                    -----------------------------------

                                 COPIES TO:
                          STUART H. GELFOND, ESQ.
                  FRIED, FRANK, HARRIS, SHRIVER & JACOBSON
                             ONE NEW YORK PLAZA
                          NEW YORK, NEW YORK 10004
                               (212) 859-8000

                    -----------------------------------

     APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From
time to time after this Registration Statement becomes effective.

     If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, please check the
following box. [_]

     If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following box. |X|

     If this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, check the
following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. [_]
_______________

     If this form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. [_] _______________

     If delivery of the prospectus is expected to be made pursuant to Rule
434, check the following box. [_]

<TABLE>
<CAPTION>

                      CALCULATION OF REGISTRATION FEE
========================= ====================== ===================== ===================== ===============
 TITLE OF EACH CLASS OF                           PROPOSED MAXIMUM      PROPOSED MAXIMUM      AMOUNT OF
    SECURITIES TO BE          AMOUNT TO BE        OFFERING PRICE PER    AGGREGATE OFFERING    REGISTRATION
       REGISTERED              REGISTERED              UNIT (1)             PRICE (1)             FEE
------------------------- ---------------------- --------------------- --------------------- ---------------
<S>                              <C>                   <C>                  <C>                 <C>
Common stock, par value          379,229               $131.98              $50,050,643          $4,604.66
  $10.00 per share,
  underlying warrants  (2)
========================= ====================== ===================== ===================== ===============
<FN>
(1)  Estimated solely for the purpose of calculating the registration fee
     pursuant to Rule 457(c) under the Securities Act of 1933, as amended,
     based on the average of the high and low per share sale price on the
     New York Stock Exchange on January 16, 2002.
 (2) The shares of our common stock being registered hereunder include the
     associated rights to purchase our Series A Preferred Stock. The rights
     to purchase our Series A Preferred Stock initially are attached to and
     trade with the shares of our common stock being registered hereby.
</FN>
</TABLE>

                     ----------------------------------

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT
SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS
REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH
SECTION 8(A) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION
STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING
PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.


<PAGE>




   The information in this prospectus is not complete and may be changed.
     The shares of common stock discussed in this prospectus may not be
    sold or otherwise transferred until the registration statement filed
     with the Securities and Exchange Commission is declared effective.
          This prospectus is not an offer to sell these securities
        and it is not soliciting an offer to buy these securities in
            any state where the offer or sale is not permitted.


               SUBJECT TO COMPLETION, DATED JANUARY 18, 2002

PROSPECTUS

                              SPX CORPORATION

                             379,229 SHARES OF

                                COMMON STOCK

                            --------------------

     This prospectus relates to the sale, from time to time, of up to
379,229 shares of our common stock by certain selling securityholders who
hold warrants issued by GCA Corporation in 1987. In June 1988 GCA was
acquired by General Signal Corporation, and in 1998 General Signal was
acquired by us, and, as a result, the warrants became exercisable for
shares of our common stock. The warrants represent the right to purchase an
aggregate of 379,229 shares of our common stock at an exercise price of
$94.5114 per share. Warrants to purchase 308,762 shares will expire on
April 23, 2002, and warrants to purchase 70,467 shares will expire on
September 1, 2002. For a further discussion of the warrants and the
applicable terms, see "The Offering--The Selling Securityholders" and
"Common Stock We May Issue Under the Warrants."

     We do not know when or how the selling securityholders intend to sell
the shares of our common stock or what the price, terms or conditions of
any sales will be. The selling securityholders may sell the shares of our
common stock directly or through underwriters, dealers or agents, who may
receive compensation. The selling securityholders may sell the shares of
our common stock in privately negotiated transactions and may also sell the
shares in market transactions. See "Plan of Distribution." We will not
receive any proceeds from the sale of our common stock by the selling
securityholders. However, we will receive the exercise price of the
warrants if and when they are exercised.

     Our common stock trades on the New York Stock Exchange and the Pacific
Stock Exchange under the symbol "SPW." On January 17, 2002, the last
reported sale price of our common stock on the NYSE was $128.50.

     INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE "RISK FACTORS"
BEGINNING ON PAGE 5.

                            --------------------

     Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus. Any representation
to the contrary is a criminal offense.

                            --------------------


              The date of this prospectus is           , 2002


<PAGE>

                             TABLE OF CONTENTS

                                                                     Page
                                                                     ----
WHERE YOU CAN FIND MORE INFORMATION.....................................1
FORWARD-LOOKING STATEMENTS..............................................2
PROSPECTUS SUMMARY......................................................2
SPX CORPORATION.........................................................3
THE OFFERING............................................................3
RISK FACTORS............................................................5
USE OF PROCEEDS........................................................12
BUSINESS...............................................................12
COMMON STOCK WE MAY ISSUE UNDER THE WARRANTS...........................14
SELLING SECURITYHOLDERS................................................17
PLAN OF DISTRIBUTION...................................................18
LEGAL MATTERS..........................................................19
EXPERTS................................................................19

                           --------------------


<PAGE>

                    WHERE YOU CAN FIND MORE INFORMATION

     We file annual, quarterly and special reports, proxy statements and
other information with the SEC. You may read and copy any reports,
statements or other information we file with the SEC at its public
reference rooms at 450 Fifth Street, N.W., Washington, D.C. 20549. Please
call the SEC at 1-800-SEC-0330 for further information on the public
reference rooms. Our filings are also available to the public on the
Internet, through a database maintained by the SEC at http://www.sec.gov.
In addition, you can inspect and copy our reports, statements and other
information at the offices of the New York Stock Exchange, Inc., 20 Broad
Street, New York, New York 10005 or at the offices of the Pacific Stock
Exchange, 301 Pine Street, San Francisco, California 94104.

     We filed a registration statement on Form S-3 to register with the SEC
the sale of the common stock described in this prospectus. This prospectus
is part of that registration statement. As permitted by SEC rules, this
prospectus does not contain all the information contained in the
registration statement or the exhibits to the registration statement. You
may refer to the registration statement and accompanying exhibits for more
information about us and our securities.

     The SEC allows us to incorporate by reference into this document the
information we filed with it. This means that we can disclose important
business, financial and other information to you by referring you to other
documents separately filed with the SEC. All information incorporated by
reference is part of this document, unless and until that information is
updated and superseded by the information contained in this document or any
information subsequently incorporated by reference.

     We incorporate by reference the documents listed below:

     1.   Our annual report on Form 10-K/A for the fiscal year ended
          December 31, 2000;

     2.   Our quarterly reports on Form 10-Q for the fiscal quarters ended
          March 31, 2001, June 30, 2001 and September 30, 2001;

     3.   Our current reports on Form 8-K filed on March 12, 2001, April
          12, 2001, April 13, 2001, May 8, 2001, June 7, 2001 and September
          26, 2001 and on Form 8K/A filed on August 6, 2001; and

     4.   Our Definitive Proxy Statement on Schedule 14A filed on March 27,
          2001.

     You may request a copy of these filings, at no cost, by writing or
telephoning us at the following address:

                           Investor Relations
                           SPX Corporation
                           2300 One Wachovia Center
                           301 South College Street
                           Charlotte, North Carolina  28202-6039
                           Tel:  (704) 347-6800, Fax:  (704) 347-6900

     Exhibits to the filings will not be sent, however, unless those
exhibits have specifically been incorporated by reference.

     We also incorporate by reference all future filings we make with the
SEC under Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act
of 1934 (i) on or after the date of the filing of the registration
statement containing this prospectus and prior to the effectiveness of such
registration statement and (ii) on or after the date of this prospectus
until all of the shares of our common stock offered by selling
securityholders have been sold. Such documents will become a part of this
prospectus from the date that the documents are filed with the SEC.

     Our subsidiary, Inrange Technologies Corporation, completed its
initial public offering on September 27, 2000. Inrange's common stock is
traded on the Nasdaq National Market under the symbol "INRG." You may
obtain information about Inrange from the SEC at the address or website
specified above.

     You should rely only on the information contained or incorporated by
reference in this prospectus and any prospectus supplement. We have not
authorized any other person to provide you with different information. If
anyone provides you with different or inconsistent information, you should
not rely on it. We are not making an offer to sell these securities in any
jurisdiction where the offer and sale is not permitted. You should assume
that the information appearing or incorporated by reference in this
prospectus is accurate only as of the date of the documents containing the
information. Our business, financial condition, results of operation and
prospects may have changed since that date.

                         FORWARD-LOOKING STATEMENTS

     Some of the statements in this prospectus and any documents
incorporated by reference constitute "forward looking statements" within
the meaning of the U.S. Private Securities Litigation Reform Act of 1995.
These statements relate to future events or our future financial
performance, including, but not limited to, cost savings and other benefits
of acquisitions, including the acquisition of UDI, which involve known and
unknown risks, uncertainties and other factors that may cause our or our
businesses' actual results, levels of activity, performance or achievements
to be materially different from those expressed or implied by any forward
looking statements. In some cases, you can identify forward looking
statements by terminology such as "may," "will," "could," "would,"
"should," "expect," "plan," "anticipate," "intend," "believe," "estimate,"
"predict," "potential" or "continue" or the negative of those terms or
other comparable terminology. These statements are only predictions. Actual
events or results may differ materially because of market conditions in our
industries or other factors. Moreover, we do not, nor does any other
person, assume responsibility for the accuracy and completeness of those
statements. We have no duty to update any of the forward looking statements
after the date of this prospectus to conform them to actual results. All of
the forward looking statements are qualified in their entirety by reference
to the factors discussed under the captions "Risk Factors" in the
prospectus, "Other Matters" in "Management's Discussion and Analysis of
Results of Operations and Financial Condition" in our Form 10-Q for the
fiscal quarters ended March 31, 2001 and June 30, 2001 (each incorporated
by reference in this prospectus) and in "Management's Discussion and
Analysis of Financial Condition and Results of Operations" in our Form 10-Q
for the fiscal quarter ended September 30, 2001 (incorporated by reference
in this prospectus) and "Factors That May Affect Future Results" in
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" of our most recent Form 10-K/A (incorporated by reference in
this prospectus) and similar sections in our future filings which we
incorporate by reference in this prospectus, which describe risks and
factors that could cause results to differ materially from those projected
in such forward looking statements.

     We caution the reader that these risk factors may not be exhaustive.
We operate in a continually changing business environment, and new risk
factors emerge from time to time. Management cannot predict such new risk
factors, nor can it assess the impact, if any, of such new risk factors on
our businesses or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those projected
in any forward looking statements. Accordingly, forward looking statements
should not be relied upon as a prediction of actual results. In addition,
management's estimates of future operating results are based on our current
complement of businesses, which is constantly subject to change as
management implements its "fix, sell or grow" strategy.

                             PROSPECTUS SUMMARY

     You should read the following summary together with the more detailed
information appearing elsewhere in this prospectus. The following summary
is qualified in its entirety by the information contained elsewhere or
incorporated by reference in this prospectus.

     In this prospectus:

          o    "SPX," "the company," "we," "us," and "our" refer to SPX
               Corporation, a Delaware corporation, and its consolidated
               subsidiaries, unless the context otherwise requires;

          o    "UDI" refers to United Dominion Industries Limited and its
               subsidiaries, all of which are subsidiaries of SPX
               Corporation, unless the context otherwise requires;

          o    "February LYONs" refers to our Liquid Yield Option
               Notes(TM) due 2021 issued in February 2001; and

          o    "May LYONs" refers to our Liquid Yield Option Notes(TM) due
               2021 issued in May 2001.

                              SPX CORPORATION

     We are a global provider of technical products and systems, industrial
products and services, flow technology and service solutions. We offer a
diversified collection of products that includes networking and switching
products, fire detection and building life-safety products, TV and radio
broadcast antennas and towers, life science products and services,
transformers, compaction equipment, high-integrity castings, dock products
and systems, cooling towers, air filtration products, valves, back-flow
protection devices and fluid handling, metering and mixing solutions. Our
products and services also include specialty service tools, diagnostic
systems, service equipment and technical information services. Our products
are used by a broad group of customers that serve a diverse group of
industries including chemical processing, pharmaceuticals, infrastructure,
mineral processing, petrochemical, telecommunications, financial services,
transportation and power generation. Our common stock is publicly traded on
the New York Stock Exchange and the Pacific Stock Exchange under the symbol
"SPW."

     We are a global multi-industry company that is focused on profitably
growing our businesses that have scale and growth potential. Our strategy
is to create market advantages through product and technology leadership,
by expanding our service offerings to full customer solutions and by
building critical mass through strategic acquisitions. We continually
review each of our businesses pursuant to our "fix, sell or grow" strategy.
These reviews could result in selected acquisitions to expand an existing
business or result in the disposition of an existing business. At any given
time, we may engage in discussions with respect to potential acquisitions
in related or unrelated industries, asset sales and joint ventures, some of
which may be material.

     On May 24, 2001, we completed the acquisition of United Dominion
Industries Limited, or UDI, in an all-stock transaction valued at $1,066.9
million. A total of 9.385 million shares were issued (3.890 million from
treasury) to complete the transaction. We also assumed or refinanced $884.1
million of UDI debt bringing the total transaction value to $1,951.0
million. UDI manufactures proprietary engineered and flow technology
products primarily for industrial and commercial markets worldwide. UDI,
which had sales of $2,366.2 million in 2000, is included in our financial
statements beginning May 25, 2001 and is represented in the description of
our company.

     We are a Delaware corporation. Our principal executive offices are
located at 2300 One Wachovia Center, 301 South College Street, Charlotte,
North Carolina 28202-6039, and our telephone number is (704) 347-6800.


                            --------------------

                               THE OFFERING

Common stock outstanding as of
December 26, 2001........................    40,420,975 shares.*

Common stock being registered for selling
securityholders..........................    379,229 shares.

Use of Proceeds..........................    We will not receive any of the
                                             proceeds from the sales of
                                             common stock by the selling
                                             securityholders. However, if
                                             one or more of the selling
                                             securityholders exercises its
                                             rights under the warrants, we
                                             could receive up to
                                             $35,841,463 in gross proceeds
                                             representing the exercise
                                             price for the shares of common
                                             stock underlying the warrants.
                                             All of the proceeds that we
                                             receive, if any, will be used
                                             for general corporate
                                             purposes.

NYSE and PSE symbol......................    SPW.



*   The common stock outstanding as of December 26, 2001 excludes the
following: (A) approximately 6.6 million shares issuable upon conversion of
our February LYONs and our May LYONs; (B) approximately 8.7 million shares
issuable upon exercise of outstanding stock options by employees and
non-employee directors; and (C) approximately 5.7 million shares of our
common stock reserved for future issuance of additional options and shares
under our employee stock option plan and non-employee director stock option
plan. Each of the amounts is subject to adjustment as specified in the
appropriate documents.

THE SELLING SECURITYHOLDERS

     We have prepared this prospectus in connection with the registration
of the resale of shares of our common stock underlying warrants issued in
1987 by GCA Corporation, a company acquired by General Signal Corporation
in 1988. The warrants were issued to GCA's bank and insurance company
lenders and to one vendor and represented the right to purchase GCA common
stock. As a result of the acquisition of GCA by General Signal and the
subsequent acquisition of General Signal by us, the warrants now represent
the right to purchase shares of our common stock at an exercise price of
$94.5114 per share. The warrants issued to GCA's bank and insurance company
lenders presently represent the right to purchase 308,762 shares of our
common stock and are exercisable through April 23, 2002. The warrants
issued to the vendor presently represent the right to purchase 70,467
shares of our common stock and are exercisable through September 1, 2002.
We are registering these shares in satisfaction of GCA's obligation to
register these shares under registration agreements entered into between
these selling securityholders and GCA in connection with the issuance of
the warrants described above.

RISK FACTORS

     In evaluating an investment in our common stock, you should carefully
consider all the information included or incorporated by reference in this
prospectus. In particular, you should evaluate the specific risk factors
set forth under "Risk Factors," beginning on page 5 of the prospectus as
updated by information under the caption "Legal Proceedings" in our Form
10-Q for the fiscal quarter ended September 30, 2001.

                            --------------------

<PAGE>

                                RISK FACTORS

     You should carefully consider the risks described below before making
a decision to invest in our common stock. Some of the following factors
relate principally to our business and the industry in which we operate.
Other factors relate principally to your investment in our common stock.
The risks and uncertainties described below are not the only ones facing
our company. Additional risks and uncertainties not presently known to us
or that we currently deem immaterial may also adversely affect our business
and operations.

     If any of the matters included in the following risks were to occur,
our business, financial condition, results of operations, cash flows or
prospects could be materially adversely affected. In such case, the trading
price of our common stock could decline and you could lose all or part of
your investment.

OUR LEVERAGE MAY AFFECT OUR BUSINESS AND MAY RESTRICT OUR OPERATING
FLEXIBILITY.

     At September 30, 2001, we had approximately $2,709.1 million in total
indebtedness. At such date, we had $530.1 million of available borrowing
capacity under our revolving senior credit facility after giving effect to
$69.9 million reserved for letters of credit outstanding which reduce the
availability under our revolving senior credit facility. In addition, at
September 30, 2001, our cash balance was $340.5 million. For a description
of our indebtedness, please see "Management's Discussion and Analysis of
Results of Operations and Financial Condition" in our quarterly reports on
Form 10-Q for the fiscal quarters ended March 31, 2001 and June 30, 2001
and in "Management's Discussion and Analysis of Financial Condition and
Results of Operations" in our Form 10-Q for the fiscal quarter ended
September 30, 2001 and "Management's Discussion and Analysis of Financial
Condition and Results of Operations" in our annual report on Form 10-K/A
for the fiscal year ended December 31, 2000 and any future Forms 10-Q and
10-K which we file, which are incorporated by reference in this prospectus.
Subject to certain restrictions set forth in the senior credit facility, we
may incur additional indebtedness in the future, including indebtedness
incurred to finance, or which is assumed in connection with, acquisitions.
We may in the future renegotiate or refinance our senior credit facility
with agreements that have different or more stringent terms or split our
senior credit facility into two or more facilities with different terms.
The level of our indebtedness could:

          o    limit cash flow available for general corporate purposes,
               such as acquisitions and capital expenditures, due to the
               ongoing cash flow requirements for debt service;

          o    limit our ability to obtain, or obtain on favorable terms,
               additional debt financing in the future for working capital,
               capital expenditures or acquisitions;

          o    limit our flexibility in reacting to competitive and other
               changes in the industry and economic conditions generally;

          o    expose us to a risk that a substantial decrease in net
               operating cash flows due to economic developments or adverse
               developments in our business could make it difficult to meet
               debt service requirements; and

          o    expose us to risks inherent in interest rate fluctuations
               because the existing borrowings are and any new borrowings
               may be at variable rates of interest, which could result in
               higher interest expense in the event of increases in
               interest rates.

     Our ability to make scheduled payments of principal of, to pay
interest on, or to refinance our indebtedness and to satisfy our other debt
obligations will depend upon our future operating performance, which may be
affected by general economic, financial, competitive, legislative,
regulatory, business and other factors beyond our control. We will not be
able to control many of these factors, such as the economic conditions in
the markets in which we operate and initiatives taken by our competitors.
In addition, there can be no assurance that future borrowings or equity
financing will be available for the payment or refinancing of our
indebtedness. If we are unable to service our indebtedness, whether in the
ordinary course of business or upon acceleration of such indebtedness, we
may be forced to pursue one or more alternative strategies, such as
restructuring or refinancing our indebtedness, selling assets, reducing or
delaying capital expenditures or seeking additional equity capital. There
can be no assurance that any of these strategies could be effected on
satisfactory terms, if at all.

WE MAY NOT BE ABLE TO FINANCE FUTURE NEEDS OR ADAPT OUR BUSINESS PLAN TO
CHANGES IN ECONOMIC OR BUSINESS CONDITIONS BECAUSE OF RESTRICTIONS PLACED
ON US BY OUR SENIOR CREDIT FACILITY AND THE INSTRUMENTS GOVERNING OUR OTHER
INDEBTEDNESS.

     Our senior credit facility and other agreements governing our other
indebtedness contain or may contain covenants that restrict our ability to
make distributions or other payments to our investors and creditors unless
certain financial tests or other criteria are satisfied. We must also
comply with certain specified financial ratios and tests. In some cases,
our subsidiaries are subject to similar restrictions which may restrict
their ability to make distributions to us. In addition, our senior credit
facility and these other agreements contain or may contain additional
affirmative and negative covenants. All of these restrictions could affect
our ability to operate our business and may limit our ability to take
advantage of potential business opportunities such as acquisitions as they
arise.

     If we do not comply with these or other covenants and restrictions
contained in our senior credit facility and other agreements governing our
indebtedness, we could be in default under those agreements, and the debt,
together with accrued interest, could then be declared immediately due and
payable. If we default under our senior credit facility, the lenders could
cause all of our outstanding debt obligations under our senior credit
facility to become due and payable, require us to apply all of our cash to
repay the indebtedness or prevent us from making debt service payments on
any other indebtedness we owe. In addition, any default under our senior
credit facility or agreements governing our other indebtedness could lead
to an acceleration of debt under other debt instruments that contain
cross-acceleration or cross-default provisions. If the indebtedness under
our senior credit facility is accelerated, we may not have sufficient
assets to repay amounts due under our senior credit facility, the February
LYONs, the May LYONs or under other debt securities then outstanding. Our
ability to comply with these provisions of our senior credit facility and
other agreements governing our other indebtedness may be affected by
changes in the economic or business conditions or other events beyond our
control.

OUR FAILURE TO SUCCESSFULLY INTEGRATE UDI AND OTHER RECENT ACQUISITIONS, AS
WELL AS ANY FUTURE ACQUISITIONS, COULD HAVE A NEGATIVE EFFECT ON OUR
OPERATIONS; OUR ACQUISITIONS COULD CAUSE UNEXPECTED FINANCIAL DIFFICULTIES.

     As part of our business strategy, we evaluate potential acquisitions
in the ordinary course. In 2000, we made 21 acquisitions of businesses for
an aggregate price of approximately $226.8 million. Excluding the UDI
acquisition, in the first nine months of 2001, we made thirteen
acquisitions of businesses for an aggregate purchase price of approximately
$453.6 million. Our past acquisitions, particularly the acquisition of UDI
which had sales of approximately $2,366.2 million for the year ended
December 31, 2000, and any potential future acquisitions, involve a number
of risks and present financial, managerial and operational challenges,
including:

          o    adverse effects on our reported operating results due to
               charges to earnings and the amortization of goodwill
               associated with acquisitions;

          o    diversion of management attention from running our existing
               businesses;

          o    difficulty with integration of personnel and financial and
               other systems;

          o    increased expenses, including compensation expenses
               resulting from newly-hired employees;

          o    increased foreign operations which may be difficult to
               assimilate;

          o    assumption of known and unknown liabilities and increased
               litigation; and

          o    potential disputes with the sellers of acquired businesses,
               technologies, services or products.

     We may not be able to integrate successfully the technology,
operations and personnel of any acquired business. Customer dissatisfaction
or performance problems with an acquired business, technology, service or
product could also have a material adverse effect on our reputation and
business. In addition, any acquired business, technology, service or
product could underperform relative to our expectations. We could also
experience financial or other setbacks if any of the businesses that we
have acquired or may acquire in the future have problems or liabilities of
which we are not aware or which are substantially greater than we
anticipate. In addition, as a result of future acquisitions, we may further
increase our leverage or, if we issue equity securities to pay for the
acquisitions, significantly dilute our existing securityholders.

WE MAY NOT ACHIEVE THE EXPECTED COST SAVINGS AND OTHER BENEFITS OF OUR
ACQUISITIONS, INCLUDING UDI.

     As a result of our acquisitions, including the acquisition of UDI, we
incur integration expenses for the incremental costs to exit and
consolidate activities, to involuntarily terminate employees, and for other
costs to integrate operating locations and other activities of these
companies with SPX. Generally accepted accounting principles require that
these acquisition integration expenses, which are not associated with the
generation of future revenues and have no future economic benefit, be
reflected as assumed liabilities in the allocation of the purchase price to
the net assets acquired. On the other hand, these same principles require
that acquisition integration expenses associated with integrating SPX
operations into locations of the acquired company's must be recorded as
expense. Accordingly, these expenses are not included in the allocation of
purchase price of the company acquired. Over the past five years, we have
recorded several special charges to our results of operations associated
with cost reductions, integrating acquisitions and achieving operating
efficiencies. We believe that our actions have been required to improve our
operations and, as described above, we will, if necessary, record future
charges as appropriate to address costs and operational efficiencies at the
combined company.

     We believe our anticipated savings from the cost reduction and
integration actions associated with the UDI acquisition should exceed
$120.0 million on an annualized basis. Our current integration plan focuses
on three key areas of cost savings: (1) manufacturing process and supply
chain rationalization, including plant closings, (2) elimination of
redundant administrative overhead and support activities, and (3)
restructuring and repositioning sales and marketing organizations to
eliminate redundancies in these activities. While we believe these cost
savings to be reasonable and significant cost reductions have been achieved
to date, they are inherently estimates which are difficult to predict and
are necessarily speculative in nature. In addition, we cannot assure you
that unforeseen factors will not offset the estimated cost savings or other
benefits from the acquisition. As a result, our actual cost savings, if
any, and other anticipated benefits could differ or be delayed, compared to
our estimates and from the other information contained in this prospectus.

WE MAY NOT BE ABLE TO CONSUMMATE ACQUISITIONS AT OUR PRIOR RATE WHICH COULD
NEGATIVELY IMPACT US.

     We may not be able to consummate acquisitions at similar rates to our
past acquisition rates, which could materially impact our growth rate,
results of operations and stock price. Our ability to continue to achieve
our goals may depend upon our ability to identify and successfully acquire
companies, businesses and product lines, to effectively integrate these
businesses and achieve cost effectiveness. We may also need to raise
additional funds to consummate these acquisitions. In addition, changes in
our stock price may adversely affect our ability to consummate
acquisitions.

THE LOSS OF KEY PERSONNEL AND ANY INABILITY TO ATTRACT AND RETAIN QUALIFIED
EMPLOYEES COULD MATERIALLY ADVERSELY IMPACT OUR OPERATIONS.

     We are dependent on the continued services of our management team,
including our Chairman of the Board, President and Chief Executive Officer.
The loss of such personnel without adequate replacement could have a
material adverse effect on us. Additionally, we need qualified managers and
skilled employees with technical and manufacturing industry experience in
order to operate our business successfully. From time to time there may be
a shortage of skilled labor which may make it more difficult and expensive
for us to attract and retain qualified employees. If we are unable to
attract and retain qualified individuals or our costs to do so increase
significantly, our operations would be materially adversely affected.

MANY OF THE INDUSTRIES IN WHICH WE OPERATE ARE CYCLICAL AND, ACCORDINGLY,
OUR BUSINESS IS SUBJECT TO CHANGES IN THE ECONOMY; PRESSURE FROM ORIGINAL
EQUIPMENT MANUFACTURERS TO REDUCE COSTS COULD ADVERSELY AFFECT OUR
BUSINESS; OUR BUSINESS WAS IMPACTED BY THE TERRORIST ATTACKS ON SEPTEMBER
11, 2001.

     Many of the business areas in which we operate are subject to specific
industry and general economic cycles. Certain businesses are subject to
industry cycles, including, but not limited to, the automotive industries
which influence our Service Solutions and Industrial Products and Services
segments, the electric power and construction and infrastructure markets
which influence our Industrial Products and Services segment, the
telecommunications networks and building construction industries which
influence our Technical Products and Systems segment, and process
equipment, chemical and petrochemical markets which influence our Flow
Technology segment. Accordingly, any downturn in these or other markets in
which we participate could materially adversely affect us. A decline in
automotive sales and production may also affect not only sales of
components, tools and services to vehicle manufacturers and their
dealerships, but also sales of components, tools and services to
aftermarket customers, and could result in a decline in our results of
operations or a deterioration in our financial condition. Similar cyclical
changes could also affect aftermarket sales of products in our other
segments. If demand changes and we fail to respond accordingly, our results
of operations could be materially adversely affected in any given quarter.
The business cycles of our different operations may occur
contemporaneously.

     Consistent with most multi-industry, capital goods companies, our
businesses have been impacted in 2001 by the soft economic conditions.
There can be no assurance that the economic downturn will not worsen or
that we will be able to sustain existing or create additional cost
reductions to offset economic conditions, and the unpredictability and
changes in the industrial markets in the current environment could continue
and may adversely impact our results.

     There is also substantial and continuing pressure from the major
original equipment manufacturers, particularly in the automotive industry,
to reduce costs, including the cost of products and services purchased from
outside suppliers such as us. If in the future we were unable to generate
sufficient cost savings to offset price reductions, our gross margins could
be materially adversely affected.

IF FUTURE CASH FLOWS ARE INSUFFICIENT TO RECOVER THE CARRYING VALUE OF OUR
GOODWILL, A MATERIAL NON-CASH CHARGE TO EARNINGS COULD RESULT.

     At September 30, 2001, we had goodwill and intangible assets of
approximately $2,994.8 million and shareholders' equity of approximately
$1,617.9 million. On an ongoing basis, we evaluate, based on projected
undiscounted cash flows, whether we will be able to recover all or a
portion of the carrying value of goodwill. Based on this method, we expect
to recover the carrying value of goodwill through our future cash flows. If
future cash flows are insufficient to recover the carrying value of our
goodwill, we must write off a portion of the unamortized balance of
goodwill. There can be no assurance that circumstances will not change in
the future that will affect the useful life or carrying value of our
goodwill and accordingly require us to take a charge to write off a portion
of our goodwill.

     In July 2001 the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 141 "Business Combinations" ("SFAS
141") and Statement of Financial Accounting Standards No. 142 "Goodwill and
Other Intangible Assets" ("SFAS 142"). We will adopt SFAS 141 and SFAS 142
for our fiscal year beginning on January 1, 2002. We are currently
evaluating the impact that adoption of SFAS 141 and SFAS 142 will have on
our financial position and results of operations.

WE ARE SUBJECT TO ENVIRONMENTAL AND SIMILAR LAWS AND POTENTIAL LIABILITY
RELATING TO CERTAIN CLAIMS, COMPLAINTS AND PROCEEDINGS, INCLUDING THOSE
RELATING TO ENVIRONMENTAL AND OTHER MATTERS, ARISING IN THE ORDINARY COURSE
OF BUSINESS.

     We are subject to various environmental laws, ordinances, regulations,
and other requirements of government authorities in the United States and
other nations. Such requirements may include, for example, those governing
discharges from, and materials handled as part of, our operations, the
remediation of soil and groundwater contaminated by petroleum products or
hazardous substances or wastes, and the health and safety of our employees.
Under certain of these laws, ordinances or regulations, a current or
previous owner or operator of property may be liable for the costs of
investigation, removal or remediation of certain hazardous substances or
petroleum products on, under, or in its property, without regard to whether
the owner or operator knew of, or caused, the presence of the contaminants,
and regardless of whether the practices that resulted in the contamination
were legal at the time they occurred. The presence of, or failure to
remediate properly, such substances may have adverse effects, including,
for example, substantial investigative or remedial obligations, and limits
on the ability to sell or rent such property or to borrow funds using such
property as collateral. In connection with our acquisitions and
divestitures, we may assume or retain significant environmental liabilities
some of which we may not be aware. In particular, we assumed additional
environmental liabilities in connection with the UDI acquisition. Future
developments related to new or existing environmental matters or changes in
environmental laws or policies could lead to material costs for
environmental compliance or cleanup. There can be no assurance that such
liabilities and costs will not have a material adverse effect on our
results of operations or financial position in the future.

     Numerous claims, complaints and proceedings arising in the ordinary
course of business, including but not limited to those relating to
environmental matters, competitive issues, contract issues, intellectual
property matters, personal injury and product liability claims, and
workers' compensation have been filed or are pending against us and certain
of our subsidiaries. We have insurance and indemnification for a portion of
such items. In our opinion, these matters are individually or in the
aggregate either without merit or are of a kind as should not have a
material adverse effect on our financial position, results of operations,
or cash flows if disposed unfavorably. However, there can be no assurance
that recoveries for insurance and indemnification will be available or that
any such claims or other matters could not have a material adverse effect
on our financial position, results of operations or cash flows.
Additionally, in connection with our acquisitions, we may become subject to
significant claims of which we were unaware at the time of the acquisition
or the claims that we were aware of may result in our incurring a
significantly greater liability than we anticipated.

     On or about October 29, 2001, we were served with a complaint by VSI
Holdings, Inc. seeking enforcement of a merger agreement that we had
terminated. In its complaint, VSI asked the court to require us to complete
the $197.0 million acquisition of VSI, and/or award damages to VSI and its
shareholders. We do not believe the suit has merit and are defending the
claim vigorously. On December 26, 2001, we filed our answer denying VSI's
allegations, raising affirmative defenses, and asserting a counterclaim
against VSI for breach of contract. There can be no assurance that we will
be successful in the litigation. If we are not successful, the outcome
could have a material adverse effect on our financial condition and results
of operations.

OUR INRANGE SUBSIDIARY IS SUBJECT TO VARIOUS RISKS AND ANY MATERIAL ADVERSE
EFFECT ON INRANGE COULD MATERIALLY ADVERSELY AFFECT OUR FINANCIAL RESULTS.

     We own approximately 89.5% of the total number of outstanding shares
of common stock of Inrange Technologies Corporation. Based on the closing
price of Inrange's Class B common stock on January 15, 2002, Inrange's
market capitalization was approximately $1,095.8 million on such date.
Inrange is a high technology company and is subject to additional and
different risks, and its public equity trades similar to other technology
businesses.

     The terrorist events of September 11, 2001 have had a material effect
on Inrange's business. Inrange's near-term business may be impacted by the
following factors:

          o    customer buying decisions being delayed;

          o    travel restrictions, which impacts sales efforts; and

          o    Inrange's largest world-wide sales office adjacent to the
               World Trade Center was closed indefinitely which has
               required us to relocate our sales force to a newly acquired
               operation in New Jersey.

The impact to Inrange's business subsequent to the events on September 11,
2001 reduced its third quarter 2001 results and as a consequence, will
negatively affect the full 2001 year results. Inrange's business could be
adversely impacted by the continued economic softening. Any adverse effect
on Inrange could affect us.

     In addition to the risks described herein for our business as a whole,
Inrange is subject to the following risks:

          o    Inrange's business will suffer if it fails to develop,
               successfully introduce and sell new and enhanced high
               quality, technologically advanced cost-effective products
               that meet the changing needs of its customers on a timely
               basis. Inrange's competitors may develop new and more
               advanced products on a regular basis;

          o    Inrange relies on a sole manufacturer to produce one of its
               key products and on sole sources of supply for some key
               components in its products. Any disruption in these
               relationships could increase product costs and reduce
               Inrange's ability to provide its products or develop new
               products on a timely basis; and

          o    The price for Inrange's products may decrease in response to
               competitive pricing pressures, maturing life cycles, new
               product introductions and other factors. Accordingly,
               Inrange's profitability may decline unless it can reduce its
               production and sales costs or develop new higher margin
               products.

     The foregoing is a summary of the risk factors applicable to Inrange.
For a more complete description of those risks, please see "Risk Factors"
in Inrange's annual report of Form 10-K for the fiscal year ended December
31, 2000, which section is hereby incorporated by reference in this
prospectus. See "Where You Can Find More Information."

DIFFICULTIES PRESENTED BY INTERNATIONAL ECONOMIC, POLITICAL, LEGAL,
ACCOUNTING AND BUSINESS FACTORS COULD NEGATIVELY AFFECT OUR INTERESTS AND
BUSINESS EFFORT.

     In 2000, on a pro forma basis for our acquisition of UDI,
approximately 27% of our sales were international, including export sales.
In addition, in 2000, approximately 40% of Inrange's sales were
international, including export sales. We are seeking to increase our sales
outside the United States. Our international operations require us to
comply with the legal requirements of foreign jurisdictions and expose us
to the political consequences of operating in foreign jurisdictions. Our
foreign business operations are also subject to the following risks:

          o    difficulty in managing, operating and marketing our
               international operations because of distance, as well as
               language and cultural differences;

          o    increased strength of the U.S. dollar will increase the
               effective price of our products sold in U.S. dollars which
               may have a material adverse effect on sales or require us to
               lower our prices and also decrease our reported revenues or
               margins in respect of sales conducted in foreign currencies
               to the extent we are unable or determine not to increase
               local currency prices; likewise, decreased strength of the
               U.S. dollar could have a material adverse effect on the cost
               of materials and products purchased overseas;

          o    difficulty entering new international markets due to greater
               regulatory barriers than the United States and differing
               political systems;

          o    increased costs due to domestic and foreign customs and
               tariffs, potentially adverse tax consequences, including
               imposition or increase of withholding and other taxes on
               remittances and other payments by subsidiaries, and
               transportation and shipping expenses;

          o    credit risk or financial condition of local customers and
               distributors;

          o    potential difficulties in staffing and labor disputes;

          o    risk of nationalization of private enterprises;

          o    increased costs of transportation or shipping;

          o    ability to obtain supplies from foreign vendors and ship
               products internationally during times of crisis or
               otherwise;

          o    potential difficulties in protecting intellectual property;

          o    potential imposition of restrictions on investments; and

          o    local political and social conditions, including the
               possibility of hyperinflationary conditions and political
               instability in certain countries.

     As we continue to expand our international operations, including as a
result of the UDI acquisition, these and other risks associated with
international operations are likely to increase. In addition, as we enter
new geographic markets, we may encounter significant competition from the
primary participants in such markets, some of which may have substantially
greater resources than we do.

FUTURE INCREASES IN THE NUMBER OF SHARES OF OUR OUTSTANDING COMMON STOCK
COULD ADVERSELY AFFECT OUR COMMON STOCK PRICE OR DILUTE OUR EARNINGS PER
SHARE.

     Sales of a substantial number of shares of common stock into the
public market, or the perception that these sales could occur, could have a
material adverse effect on our stock price. If certain conditions are met,
the February LYONs and May LYONs could be converted into shares of our
common stock. The shares covered by the February LYONs and the May LYONs
have been registered under the Securities Act. Subject to adjustment, the
February LYONs and May LYONs could be converted into an aggregate of
approximately 6.6 million shares of our common stock. In addition, as of
December 26, 2001, approximately 8.7 million shares of our common stock are
issuable upon exercise of outstanding stock options by employees and
non-employee directors. As of December 26, 2001, under our employee stock
option plan and non-employee director stock option plan, approximately 5.7
million shares of our common stock are reserved for future issuance of
additional options and shares under these plans. Additionally, we may issue
a significant number of additional shares in connection with our
acquisitions. We have also filed a shelf registration statement for 4.3
million shares of common stock which may be issued in acquisitions and we
have also filed a shelf registration statement for a total of $1,000
million which may be used in connection with an offering of debt securities
and/or common stock for general corporate purposes. Any such additional
shares could also have a dilutive effect on our earnings per share.

PROVISIONS IN OUR CORPORATE DOCUMENTS AND DELAWARE LAW MAY DELAY OR PREVENT
A CHANGE IN CONTROL OF OUR COMPANY, AND ACCORDINGLY, WE MAY NOT CONSUMMATE
A TRANSACTION THAT OUR STOCKHOLDERS CONSIDER FAVORABLE.

     Provisions of our Certificate of Incorporation and By-laws may inhibit
changes in our control not approved by our Board. We also have a rights
plan designed to make it more costly and thus more difficult to gain
control of us without the consent of our Board. We are also afforded the
protections of Section 203 of the Delaware General Corporation Law, which
could have similar effects. See "Description of Common Stock."


<PAGE>

                              USE OF PROCEEDS

     We will not receive any of the proceeds from the sales of common stock
by the selling securityholders. However, if one or more of the selling
securityholders exercises its rights under the warrants, we could receive
up to $35.8 million in gross proceeds representing the exercise price for
the shares of common stock underlying the warrants. All of the proceeds
that we receive, if any, will be used for general corporate purposes.

                                  BUSINESS

     We are a global provider of technical products and systems, industrial
products and services, flow technology and service solutions. We offer a
diversified collection of products that includes networking and switching
products, fire detection and building life-safety products, TV and radio
broadcast antennas and towers, life science products and services,
transformers, compaction equipment, high-integrity castings, dock products
and systems, cooling towers, air filtration products, valves, back-flow
protection devices and fluid handling, metering and mixing solutions. Our
products and services also include specialty service tools, diagnostic
systems, service equipment and technical information services. Our products
are used by a broad group of customers that serve a diverse group of
industries including chemical processing, pharmaceuticals, infrastructure,
mineral processing, petrochemical, telecommunications, financial services,
transportation and power generation. Our common stock is publicly traded on
the New York Stock Exchange and the Pacific Stock Exchange under the symbol
"SPW."

     We are a global multi-industry company that is focused on profitably
growing our businesses that have scale and growth potential. Our strategy
is to create market advantages through product and technology leadership,
by expanding our service offerings to full customer solutions and by
building critical mass through strategic acquisitions. We continually
review each of our businesses pursuant to our "fix, sell or grow" strategy.
These reviews could result in selected acquisitions to expand an existing
business or result in the disposition of an existing business. At any given
time, we may be in discussions with one or more parties which discussions
may be material.

     On May 24, 2001, we completed the acquisition of UDI in an all-stock
transaction valued at $1,066.9 million. A total of 9.385 million shares
were issued (3.890 million from treasury) to complete the transaction. We
also assumed or refinanced $884.1 million of UDI debt bringing the total
transaction value to $1,951.0 million. UDI manufactures proprietary
engineered and flow technology products primarily for industrial and
commercial markets worldwide. UDI, which had sales of $2,366.2 million in
2000, is included in our financial statements beginning May 25, 2001 and is
represented in the description of our company.

     In the second quarter of 2001, following the UDI acquisition, we began
operating and reporting our results of operations in four segments,
Technical Products and Systems, Industrial Products and Services, Flow
Technology and Service Solutions. The new structure aligns our financial
reporting with the current structure of our organization.

TECHNICAL PRODUCTS AND SYSTEMS

     The Technical Products and Systems segment is focused on solving
customer problems with complete technology-based systems. This segment
includes operating units that design and manufacture networking and
switching products for storage, data and telecommunications networks, fire
detection and integrated building life-safety systems, TV and radio
transmission systems, automated fare collection systems, laboratory and
industrial ovens and freezers, electrical test and measurement solutions,
cable and pipe locating devices, laboratory testing chambers, sample
preparation and processing equipment, and electrodynamic shakers.

INDUSTRIAL PRODUCTS AND SERVICES

     The Industrial Products and Services segment emphasizes introducing
new related services and products, as well as focusing on the replacement
parts and service elements of the segment. This segment includes operating
units that design, manufacture, and market power transformers, hydraulic
systems, high-integrity aluminum and magnesium die-castings, forgings,
automatic transmission filters, industrial filtration products, dock
equipment, material handling devices, electric resistance heaters, soil,
asphalt and landfill compactors, specialty farm machinery, as well as
components for the aerospace industry.

FLOW TECHNOLOGY

     The Flow Technology segment designs, manufactures, and markets
solutions and products that are used to process or transport fluids and in
heat transfer applications. This segment includes operating units that
manufacture pumps and other fluid handling machines, valves, cooling
towers, boilers, leak detection equipment, and industrial mixers.

SERVICE SOLUTIONS

     The Service Solutions segment includes operations that design,
manufacture, and market a wide range of specialty tools, hand-held
diagnostic systems and service equipment, inspection gauging systems,
precision scales, and technical and training information.


<PAGE>


                COMMON STOCK WE MAY ISSUE UNDER THE WARRANTS

      The selling securityholders are selling under this prospectus an
aggregate of up to 379,229 shares of our common stock issuable upon
exercise of the warrants. Of the warrants, 308,762 warrants are exercisable
through April 23, 2002, and 70,467 warrants are exercisable through
September 1, 2002, all at an exercise price of $94.5114 per share.

     The exercise price and number of shares of our common stock which
may be purchased upon exercise of any of the warrants are subject to
certain "anti-dilution" adjustments in the event of any:

          o    dividend or distribution on shares of common stock payable
               in our common stock;

          o    subdivision, reclassification, combination or consolidation
               of our common stock; or

          o    consolidation or merger, conveyance or transfer of all or
               substantially all of our property.


                        DESCRIPTION OF COMMON STOCK

GENERAL

     Our authorized capital stock consists of 100 million shares of common
stock, par value $10.00 per share, and 3 million shares of preferred stock,
without par value. As of December 26, 2001, 40.4 million shares of common
stock were issued and outstanding (not including treasury shares) and 0.5
million shares have been designated as Series A Preferred Stock, of which
none are issued and outstanding. The following description of our common
stock and provisions of our Certificate of Incorporation and By-laws are
only summaries and we encourage you to review complete copies of our
Certificate of Incorporation and By-laws, which we have previously filed
with the SEC.

     The holders of our common stock are entitled to have dividends
declared in cash, property, or other securities out of any of our net
profits or net assets legally available therefor as and when declared by
our Board of Directors. In the event of the liquidation or dissolution of
our business, the holders of common stock will be entitled to receive
ratably the balance of net assets available for distribution after payment
of any liquidation or distribution preference payable with respect to any
then outstanding shares of our preferred stock. Each share of common stock
is entitled to one vote with respect to matters brought before the
stockholders, except for the election of any directors who may be elected
by vote of any outstanding shares of preferred stock voting as a class.

     The rights and privileges of our common stock may be subordinate to
the rights and preferences of any of our preferred stock. The Board is
authorized to fix by resolution the designation of each series of preferred
stock, and, with respect to each series, the stated value of the shares,
the dividend rate and the dates and other provisions respecting the payment
of dividends, the provisions, if any, for a sinking fund, the preferences
of the shares in the event of the liquidation or dissolution, the
provisions, if any, respecting the redemption of the shares, subject to
applicable law, the voting rights (except that such shares shall not have
more than one vote per share), the terms, if any, upon which the shares
would be convertible into or exchangeable for any other shares, and any
other relative, participating, optional or other special rights,
qualifications, limitations or restrictions. All shares of any series of
preferred stock, as between themselves, rank equally and are identical; and
all series of preferred stock, as between themselves, rank equally and are
identical except as set forth in resolutions of the Board authorizing the
issuance of a particular series.

     Our common stock is traded on the New York Stock Exchange and the
Pacific Stock Exchange under the symbol "SPW."

DELAWARE ANTI-TAKEOVER LAW AND CERTAIN CERTIFICATE OF INCORPORATION
AND BYLAW PROVISIONS

     The provisions of Delaware law, our Certificate of Incorporation and
By-Laws may have the effect of delaying, deferring or discouraging another
person from acquiring control of our company, including takeover attempts
that might result in a premium over the market price for the shares of
common stock.

     Delaware Law

     We are subject to the provisions of Section 203 of the Delaware
General Corporation Law regulating corporate takeovers. In general, Section
203 prohibits a publicly-held Delaware corporation from engaging in a
"business combination" with an "interested stockholder" for a period of
three years after the time that the person became an interested
stockholder, unless:

          o    before the person became an "interested stockholder," the
               board of directors of the corporation approved the
               transaction in which the "interested stockholder" became an
               "interested stockholder" or approved the business
               combination;

          o    upon consummation of the transaction that resulted in the
               stockholder becoming an "interested stockholder," the
               "interested stockholder" owned at least 85% of the voting
               stock of the corporation that was outstanding at the time
               the transaction commenced. For purposes of determining the
               number of shares outstanding, shares owned by directors who
               are also officers of the corporation and shares owned by
               employee stock plans, in specified instances, are excluded;
               or

          o    at or after the time the person became an "interested
               stockholder," the business combination is approved by the
               board of directors of the corporation and authorized at an
               annual or special meeting of the stockholders by the
               affirmative vote of at least 66 2/3% of the outstanding
               voting stock which is not owned by the "interested
               stockholder."

     A "business combination" is defined generally to include mergers or
consolidations between a Delaware corporation and an "interested
stockholder," transactions with an "interested stockholder" involving the
assets or stock of the corporation or any majority-owned subsidiary,
transactions which increase an "interested stockholder's" percentage
ownership of stock of the corporation or any majority-owned subsidiary, and
receipt of various financial benefits from the corporation or any
majority-owned subsidiary. In general, an "interested stockholder" is
defined as any person or entity that is the beneficial owner of at least
15% of a corporation's outstanding voting stock or is an affiliate or
associate of the corporation and was the beneficial owner of 15% or more of
the outstanding voting stock of the corporation at any time within the past
three years.

     A Delaware corporation may opt out of this provision with an express
provision in its original certificate of incorporation or an express
provision in its certificate of incorporation or by-laws resulting from a
stockholders' amendment approved by at least a majority of the outstanding
voting shares. However, we have not opted out of this provision. The
statute could prohibit or delay mergers or other takeover or
change-in-control attempts and, accordingly, may discourage attempts to
acquire us.

     Certificate of Incorporation and By-Law Provisions

     Our Certificate of Incorporation and By-Laws provide:

          o    a staggered Board of Directors so that it would take three
               successive annual meetings to replace all directors;

          o    a prohibition on stockholder action through written
               consents;

          o    a requirement that special meetings of stockholders be
               called only by our Chairman, President and Chief Executive
               Officer or our Board;

          o    advance notice requirements for stockholder proposals and
               nominations;

          o    limitations on the ability of stockholders to amend, alter
               or repeal the By-laws;

          o    enhanced voting requirements for certain business
               combinations involving substantial stockholders;

          o    the authority of our Board of Directors to issue, without
               stockholder approval, preferred stock with such terms as our
               Board may determine; and

          o    limitations on the ability of stockholders to remove
               directors.

     Limitations of Liability and Indemnification of Directors and Officers

     Our Certificate of Incorporation limits the liability of directors to
us and our stockholders to the fullest extent permitted by Delaware law.
Specifically, a director will not be personally liable for monetary damages
for breach of fiduciary duty as a director, except for liability:

          o    for any breach of the director's duty of loyalty to us or
               our stockholders;

          o    for acts or omissions not in good faith or which involve
               intentional misconduct or a knowing violation of the law;

          o    under Section 174 of the Delaware General Corporation Law,
               which concerns unlawful payments of dividends, stock
               purchases or redemptions; or

          o    for any transaction from which the director derived an
               improper personal benefit.

     The Certificate of Incorporation provides that we shall indemnify our
officers and directors to the fullest extent permitted by the Delaware
General Corporation Law. We believe that these provisions will assist us in
attracting and retaining qualified individuals to serve as directors.

RIGHTS PLAN

     On June 25, 1996, our Board of Directors adopted a rights plan. Our
rights plan, as amended, is designed to make it more costly and thus more
difficult to gain control of us without the consent of our Board of
Directors. The description presented below is intended as a summary only
and is qualified in its entirety by reference to the rights agreement, as
amended, which is an exhibit to the registration statement of which this
prospectus is a part.

     Our rights plan provides that each of our shares of common stock will
have the right to purchase from us one one-thousandth of a share of a new
Series A Preferred Stock at a price of $200 per one-thousandth of a share,
subject to customary anti-dilution protection adjustment.

     The rights are attached to all certificates representing outstanding
shares of our common stock, and no separate right certificates have been
distributed. The rights will separate from the shares of our common stock
approximately 10 days after someone acquires beneficial ownership of 20% or
more of the outstanding common stock, or commences a tender offer or
exchange offer for 20% or more of the outstanding common stock.

     After rights separate from our common stock, certificates representing
the rights will be mailed to record holders of our common stock. Once
distributed, the separate right certificates alone will represent the
rights.

     The rights are not exercisable until the date rights separate and will
expire on June 25, 2006, unless extended or unless earlier redeemed or
exchanged by us.

     The shares of Series A Preferred Stock purchasable upon exercise of
the rights are non-redeemable. Each share of Series A Preferred Stock has a
minimum preferential quarterly dividend payment of $5.00 per share and an
amount equal to 1,000 times the dividend declared per share of common
stock. In the event of liquidation, the holders of Series A Preferred Stock
will be entitled to a minimum preferential liquidation payment of $1,000
per share but will be entitled to an aggregate amount per share equal to
1,000 times the aggregate payment per share made to holders of common
stock.

     Each share of Series A Preferred Stock will have 1,000 votes, voting
together with the shares of common stock. In the event of any merger,
consolidation or other transaction in which shares of common stock are
exchanged, each share of Series A Preferred Stock will be entitled to
receive 1,000 times the amount received per share of common stock. The
rights are protected by customary anti-dilution provisions.

     If, after any person or group becomes an acquiring person, we are
acquired in a merger or other business combination transaction or 50% or
more of our consolidated assets or earning power are sold, each holder of a
right will have a right to receive upon exercise of a right the number of
shares of common stock of the acquiring company, having a value equal to
two times the exercise price of the right. If any person or group becomes
an acquiring person, each holder of a right will have the right to receive
upon exercise that number of shares of common stock having a market value
of two times the exercise price of the right. Following the occurrence of
the events described above, rights beneficially owned by any acquiring
person at the time of such transaction will be void and may not be
exercised.

     At any time after any person or group becomes an acquiring person and
prior to the acquisition by such person or group of 50% or more of the
outstanding shares of common stock, the Board may exchange the rights
(other than rights owned by such person or group which will have become
void), in whole or in part, at an exchange ratio of one share of common
stock or one one-thousandth of a share of Series A Preferred Stock (or of a
share of a class or series of our preferred stock having equivalent rights,
preferences and privileges) per right, subject to adjustment.

     At any time prior to the acquisition by a person or group of
affiliated or associated persons of beneficial ownership of 20% or more of
the outstanding shares of common stock, the Board may redeem the rights in
whole, but not in part, at a price of $0.01 per right.

     The terms of the rights may generally be amended by the Board without
the consent of the holders of the rights.

     Until a right is exercised, the holder will have no rights as a
stockholder.

     The rights should not interfere with any merger or other business
combination approved by the Board since the rights may be redeemed by us at
the redemption price prior to the time that a person or group has acquired
beneficial ownership of 20% or more of the common stock.

TRANSFER AGENT AND REGISTRAR

     The transfer agent and registrar for our common stock is EquiServe.

                          SELLING SECURITYHOLDERS

     This prospectus covers offers and sales by the selling securityholders
of shares of our common stock issued upon exercise of the warrants. The
following table sets forth, as of the date of the prospectus, a list of
each selling securityholder who has completed a questionnaire and requested
inclusion in this prospectus and the number of shares of our common stock
beneficially owned by each of these selling securityholders, as well as the
number of shares offered for resale by each of these selling
securityholders. Shares that are beneficially owned include shares which
the selling securityholders can acquire upon exercise of the warrants (all
of which are currently exercisable) as well as shares they have already
acquired upon exercise, if any, of the warrants and shares they may have
otherwise acquired (although only sales of shares acquired upon exercise of
the warrants are covered by this prospectus). Our registration of these
shares does not necessarily mean that any named selling securityholder will
exercise its warrants or will sell all or any of its shares of common
stock. The "Shares Beneficially Owned After Offering" columns in the table
assumes that all shares covered by this prospectus will be sold by the
selling securityholders and that no additional shares of common stock are
bought or sold by any selling securityholder since the date that it
provided us with the information for the table.

     Except as may be set forth in a prospectus supplement, none of the
selling securityholders has held any position or office or had a material
relationship with us or any of its affiliates within the past three years
other than as a result of the ownership of our common stock and warrants to
purchase our common stock.

     Information about the selling securityholders may change over time.
Relevant changed or new information about selling securityholders of which
we have knowledge will be set forth in prospectus supplements. Additional
selling securityholders may also be set forth in prospectus supplements.
From time to time, additional information concerning ownership of the
shares of common stock may rest with certain holders thereof not named in
the table below and of whom we are unaware.

<TABLE>
<CAPTION>
    SHARES BENEFICIALLY OWNED PRIOR TO OFFERING (1)       SHARES TO BE       SHARES BENEFICIALLY OWNED AFTER
                                                              SOLD                  OFFERING (1) (3)

<S>                   <C>               <C>               <C>             <C>              <C>
BENEFICIAL OWNER       NUMBER OF        PERCENT                           NUMBER OF        PERCENT
                       SHARES (2)                                         SHARES
                                               *                                                    *
TOTAL                                                      __________
                                                             379,229


<FN>
* Less than one percent (1%), based upon 40,420,975 shares of common stock
outstanding as of December 26, 2001.

(1) Except as otherwise noted herein, the number and percentage of shares
beneficially owned is determined in accordance with Rule 13d-3 of the
Securities Exchange Act, and the information is not necessarily indicative
of beneficial ownership for any other purpose. Under such rule, beneficial
ownership includes any shares as to which the individual or entity has sole
or shared voting power or investment power and also any shares which the
individual or entity has the right to acquire within 60 days of the date of
this prospectus through the exercise of any stock option or other right.

(2) Includes the shares of common stock underlying the warrants which may
be sold under this prospectus.

(3) Assumes the sale of all the shares which may be sold under this prospectus.
</FN>
</TABLE>


                            PLAN OF DISTRIBUTION

     As used in this prospectus, selling securityholder includes donees,
pledgees, transferees and other successors-in-interest who sell shares
received from the selling securityholder after the date of this prospectus
as a gift, pledge, partnership distribution or other non-sale transfer.

     The selling securityholders may offer and sell the shares of our
common stock covered by this prospectus from time to time, subject to
certain restrictions. The selling securityholders will act independently of
us in making decisions with respect to the timing, manner and size of each
sale. Sales may be made:

          o    in the open market;

          o    on the New York Stock Exchange or the Pacific Stock
               Exchange;

          o    in privately negotiated transactions;

          o    in an underwritten offering; or

          o    a combination of such methods.

     Such sales may be made at varying prices determined by reference to,
among other things:

          o    market prices prevailing at the time of sale;

          o    prices related to the then-prevailing market price; or

          o    negotiated prices.

     Each selling securityholder may also transfer shares owned by it by
gift, and upon any such transfer, the donee would have the same rights as
the selling securityholder. Some of the selling securityholders may
distribute their shares, from time to time, to their limited or general
partners, members or stockholders who may sell shares pursuant to this
prospectus.

     Negotiated transactions may include purchases by a broker-dealer as
principal and resale by such broker-dealer for its account pursuant to this
prospectus, ordinary brokerage transactions and transactions in which a
broker solicits purchasers, or block trades in which a broker-dealer so
engaged will attempt to sell the shares as agent but may take a position
and resell a portion of the block as principal to facilitate the
transaction.

     Distribution by the selling securityholders of the common stock
covered by this prospectus may occur over an extended period of time. In
effecting sales, broker-dealers hired by the selling securityholders may
arrange for other broker-dealers to participate. Broker-dealers may receive
commissions or discounts from the selling securityholders in amounts to be
negotiated immediately prior to the sale.

     In connection with the sale of common stock covered by this
prospectus, underwriters or agents may receive compensation from the
selling securityholders or from purchasers of the common stock, for which
they may act as agent. Their compensation may be in the form of discounts,
concessions or commissions. If underwriters sell common stock to or through
dealers, then the dealers may receive compensation in the form of
discounts, concessions or commissions from the underwriters and/or
commissions from the purchasers for whom they act as agents. Neither we nor
any selling securityholder can presently estimate the amount of that
compensation. We know of no existing arrangements between any selling
securityholders, any other securityholders, brokers, dealers, underwriters
or agents relating to the sale or distribution of the shares of our common
stock.

     We will bear the expenses of registration under the Securities Act of
1933 as well as certain other fees and expenses. The selling
securityholders will bear the cost of any commissions or selling expenses.

                               LEGAL MATTERS

     The validity of any securities issued hereunder will be passed upon
for our company by Fried, Frank, Harris, Shriver & Jacobson (a partnership
including professional corporations), New York, New York.

                                  EXPERTS

     The consolidated financial statements of SPX as of December 31, 2000
and 1999 and for each of the three years in the period ended December 31,
2000, have been audited by Arthur Andersen LLP, independent public
accountants. These financial statements and the report of the independent
public accountants, included in SPX's Annual Report on Form 10-K/A filed on
April 12, 2001, are incorporated by reference in this document.

     The consolidated financial statements of UDI as of December 31, 2000
and 1999 and for each of the three years in the period ended December 31,
2000 have been audited by KPMG LLP, independent public accountants. These
financial statements and the report of the independent public accountants,
included in SPX's Current Report on Form 8-K filed on April 13, 2001, are
incorporated by reference in this document.


<PAGE>


                                  PART II

                   INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 14.   OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

     The following table sets forth all fees and expenses payable by the
registrant in connection with the issuance and distribution of the
securities being registered hereby (other than underwriting discounts and
commissions). All of such expenses, except the SEC registration fee, are
estimated.

Securities and Exchange Commission registration fee.....       $     4,605

New York Stock Exchange listing fee.....................             1,650

Pacific Stock Exchange listing fee......................               950

Legal fees and expenses.................................            40,000

Transfer Agent's fees and expenses......................             5,000

Accounting fees and expenses............................            15,000

Miscellaneous...........................................               795

Total...................................................        $   68,000
                                                                ==========

ITEM 15.   INDEMNIFICATION OF DIRECTORS AND OFFICERS.

LIMITATION ON LIABILITY OF DIRECTORS

     Section 145(a) of the General Corporation Law of the State of Delaware
(the "DGCL") provides that a Delaware corporation may indemnify any person
who was or is a party or is threatened to be made a party to any
threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in
the right of the corporation) by reason of the fact that such person is or
was a director, officer, employee or agent of the corporation or is or was
serving at the request of the corporation as a director, officer, employee
or agent of another corporation or enterprise, against expenses, judgments,
fines and amounts paid in settlement actually and reasonably incurred by
such person in connection with such action, suit or proceeding if he acted
in good faith and in a manner he reasonably believed to be in or not
opposed to the best interests of the corporation, and, with respect to any
criminal action or proceeding, had no cause to believe his conduct was
unlawful.

     Section 145(b) of the DGCL provides that a Delaware corporation may
indemnify any person who was or is a party or is threatened to be made a
party to any threatened, pending or completed action or suit by or in the
right of corporation to procure a judgment in its favor by reason of the
fact that such person acted in any of the capacities set forth above,
against expenses actually and reasonably incurred by such person in
connection with the defense or settlement of such action or suit if he or
she acted under similar standards to those set forth above, except that no
indemnification may be made in respect to any claim, issue or matter as to
which such person shall have been adjudged to be liable to the corporation
unless and only to the extent that the court in which such action or suit
was brought shall determine that despite the adjudication of liability, but
in view of all the circumstances of the case, such person is fairly and
reasonably entitled to be indemnified for such expenses which the court
shall deem proper.

     Section 145 of the DGCL further provides that to the extent a director
or officer of a corporation has been successful in the defense of any
action, suit or proceeding referred to in subsections (a) and (b) or in the
defense of any claim, issue or matter therein, he shall be indemnified
against expenses actually and reasonably incurred by him in connection
therewith; that indemnification provided for by Section 145 shall not be
deemed exclusive of any other rights to which the indemnified party may be
entitled; and that the corporation may purchase and maintain insurance on
behalf of a director or officer of the corporation against any liability
asserted against such officer or director and incurred by him or her in any
such capacity or arising out of his or her status as such, whether or not
the corporation would have the power to indemnify him or her against such
liabilities under Section 145.

     As permitted by Section 102(b)(7) of the DGCL, the Company's
Certificate of Incorporation provides that a director shall not be
personally liable to the Corporation or its stockholders for monetary
damages for breach of fiduciary duty as a director. However, such provision
does not eliminate or limit the liability of a director for: (i) any breach
of the director's duty of loyalty to the Corporation or its stockholders,
(ii) acts or omissions not in good faith or which involve intentional
misconduct or a knowing violation of the law, (iii) under Section 174 of
the General Corporation Law of the State of Delaware, or (iv) engaging in
any transaction from which the director derived an improper personal
benefit. The Company's Certificate of Incorporation requires that directors
and officers be indemnified to the fullest extent authorized by the DGCL,
or any other applicable law or amendments thereunder; however, in the case
of any amendments, only to the extent such amendment permits the Company to
provide broader indemnification rights than permitted prior thereto.

     Any underwriting agreements that we may enter into will likely provide
for the indemnification of the registrant, its controlling persons, its
directors and certain of its officers by the underwriters against certain
liabilities, including liabilities under the Securities Act.

     The Company has a policy of directors' liability insurance which
insures the directors and officers against the cost of defense, settlement
or payment of a judgment under certain circumstances.

ITEM 16.   EXHIBITS AND FINANCIAL STATEMENTS SCHEDULES.

     The exhibits to this registration statement are listed in the Exhibit
Index to this registration statement, which Exhibit Index is hereby
incorporated by reference.

ITEM 17.   UNDERTAKINGS.

     The undersigned registrant hereby undertakes:

           (a)(1) To file, during any period in which offers or sales are
                  being made of the securities registered hereby, a
                  post-effective amendment to this registration statement:

                  (i)   To include any prospectus required by Section
                        10(a)(3) of the Securities Act of 1933;

                  (ii)  To reflect in the prospectus any facts or events
                        arising after the effective date of this
                        registration statement (or the most recent
                        post-effective amendment thereof) which,
                        individually or in the aggregate, represent a
                        fundamental change in the information set forth in
                        the registration statement. Notwithstanding the
                        foregoing, any increase or decrease in volume of
                        securities offered (if the total dollar value of
                        securities offered would not exceed that which was
                        registered) and any deviation from the low or high
                        end of the estimated maximum offering range may be
                        reflected in the form of prospectus filed with the
                        Commission pursuant to Rule 424(b) if, in the
                        aggregate, the changes in volume and price
                        represent no more than a 20 percent change in the
                        maximum aggregate offering price set forth in the
                        "Calculation of Registration Fee" table in the
                        effective registration statement;

                  (iii) To include any material information with respect to
                        the plan of distribution not previously disclosed
                        in the registration statement or any material
                        change to such information in the registration
                        statement;

                  provided, however, that the undertakings set forth in
                  clauses (i) and (ii) above do not apply if the
                  registration statement is on Form S-3 and the information
                  required to be included in a post-effective amendment by
                  those clauses is contained in periodic reports filed by
                  the registrant pursuant to Section 13 or 15(d) of the
                  Securities Exchange Act of 1934 that are incorporated by
                  reference in this registration statement;

                  (2) That, for the purpose of determining any liability
                      under the Securities Act of 1933, each such
                      post-effective amendment shall be deemed to be a new
                      registration statement relating to the securities
                      offered therein, and the offering of such securities
                      at that time shall be deemed to be the initial bona
                      fide offering thereof;

                  (3) To remove from registration by means of a
                      post-effective amendment any of the securities being
                      registered which remain unsold at the termination of
                      the offering;

               (b)    That, for the purposes of determining any liability
                      under the Securities Act of 1933, each filing of our
                      annual report pursuant to Section 13(a) or 15(d) of
                      the Securities Exchange Act of 1934 (and, where
                      applicable, each filing of an employee benefit plan's
                      annual report pursuant to Section 15(d) of the
                      Securities Exchange Act of 1934) that is incorporated
                      by reference in this registration statement shall be
                      deemed to be a new registration statement relating to
                      the securities offered therein, and the offering of
                      such securities at that time shall be deemed to be
                      the initial bona fide offering thereof; and

               (c)    To deliver or cause to be delivered with the
                      prospectus, to each person to whom the prospectus is
                      sent or given, the latest annual report, to security
                      holders that is incorporated by reference in the
                      prospectus and furnished pursuant to and meeting the
                      requirements of Rule 14a-3 or Rule 14c-3 under the
                      Securities Exchange Act of 1934; and, where interim
                      financial information required to be presented by
                      Article 3 of Regulation S-X are not set forth in the
                      prospectus, to deliver, or cause to be delivered to
                      each person to whom the prospectus is sent or given,
                      the latest quarterly report that is specifically
                      incorporated by reference in the prospectus to
                      provide such interim financial information.

     Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers or persons
controlling the registrant, the registrant has been informed that in the
opinion of the Securities and Exchange Commission such indemnification is
against public policy as expressed in the Securities Act of 1933 and is
therefore unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of
expenses incurred or paid by a director, officer, or controlling person of
the registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as expressed in
the Act and will be governed by the final adjudication of such issue.


<PAGE>


                                 SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-3 and has duly caused
this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Charlotte, State of North
Carolina, on the 17th day of January, 2002.

                                        SPX CORPORATION

                                        /s/ Patrick J. O'Leary
                                        ------------------------------------
                                                Patrick J. O'Leary
                                        Vice President Finance, Treasurer
                                           and Chief Financial Officer

                             POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned
constitutes and appoints Patrick O'Leary, Charles Bowman and Christopher
Kearney, and each of them, his true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution, for him and in
his name, place and stead, in any and all capacities, to sign this
registration statement (including all pre-effective and post-effective
amendments thereto and all registration statements filed pursuant to Rule
462(b) which incorporate this registration statement by reference), and to
file the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto such
attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be
done in and about the premises, as fully to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that such
attorneys-in-fact and agents or any of them, or their or his substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Act of 1933, as
amended, this registration statement has been signed by the following
persons on January 17, 2002 in the capacities indicated below.

             Signature                                           Title

       /s/ John B. Blystone                          Chairman, President and
       ---------------------                          Chief Executive Officer
         John B. Blystone                          (Principal Executive Officer)

      /s/ Patrick J. O'Leary                   Vice President Finance, Treasurer
      ----------------------                      and Chief Financial Officer
        Patrick J. O'Leary                       (Principal Financial Officer)

        /s/ Ron Winowiecki                          Corporate Controller and
        ------------------                          Chief Accounting Officer
          Ron Winowiecki                          (Principal Accounting Officer)

      /s/ J. Kermit Campbell                                    Director
      -----------------------
        J. Kermit Campbell

        /s Sarah R. Coffin                                      Director
        -------------------
          Sarah R. Coffin

        /s/ Frank A. Ehmann                                     Director
        -------------------
          Frank A. Ehmann

          /s Emerson U. Fullwood                                Director
        -------------------------
          Emerson U. Fullwood

    /s/ Charles E. Johnson II                                   Director
    --------------------------
       Charles E. Johnson II

      /s/ David P. Williams                                     Director
      ----------------------
         David P. Williams


<PAGE>
                               EXHIBIT INDEX

Exhibit
Number           Description of Exhibit
------           ----------------------

     *4.1        Rights Agreement dated as of June 25, 1996 (the "Rights
                 Agreement") between SPX Corporation and The Bank of New
                 York, as Rights Agent, relating to Rights to purchase
                 preferred stock under certain circumstances, incorporated
                 herein by reference to SPX Corporation's Registration
                 Statement on Form 8-A filed on June 26, 1996.

     *4.2        Form of Amendment No. 1 to Rights Agreement, effective as
                 of October 22, 1997, between SPX Corporation and The Bank
                 of New York, incorporated herein by reference from SPX
                 Corporation's Registration Statement on Form 8-A, filed on
                 January 9, 1998.

      4.3        Warrant Agreement, dated as of April 23, 1987 (the
                 "Warrant Agreement"), among GCA Corporation, The Hallwood
                 Group Incorporated, and the banks and insurance companies
                 set forth therein.

      4.4        Warrant Agreement, dated as of September 1, 1987 (the
                 "Zeiss Warrant Agreement"), between GCA Corporation and
                 Carl Zeiss, Inc.

      4.5        Registration Agreement, dated as of April 23, 1987, among
                 GCA Corporation, the banks and insurance companies set
                 forth therein and Carl Zeiss, Inc.

      4.6        Registration Agreement, dated as of September 1, 1987,
                 among GCA Corporation and Carl Zeiss, Inc.

      4.7        Form of Warrant Certificate pursuant to the Warrant Agreement.

      4.8        Form of Warrant Certificate for Carl Zeiss, Inc. pursuant
                 to the Zeiss Warrant Agreement.

      5.1        Opinion of Fried, Frank, Harris, Shriver & Jacobson.

     23.1        Consents of Fried, Frank, Harris, Shriver & Jacobson
                 (included in Exhibit 5.1).

     23.2        Consent of Arthur Andersen LLP.

     23.3        Consent of KPMG LLP.

     24.1        Powers of Attorney (included on signature page).

------------
*  Incorporated by reference.


</TEXT>
</DOCUMENT>
